The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3)

Annals of Surgical Oncology

Volumn 15, Issue 8, 2008, Pages 2223-2234

  Nowecki, Zbigniew I ^a   Rutkowski, Piotr ^a   Michej, Wanda ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Dissection; Lymph node; Melanoma; Prognosis; Sentinel

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SENTINEL NODE MELANOMA; SEX RATIO; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 48149113440     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9965-3     Document Type: Article

References (52)

1. U Veronesi J Adamus DC Bandiera 1977 Inefficacy of immediate node dissection in stage 1 melanoma of the limbs N Engl J Med 297 627 30
2. CM Balch S Soong MI Ross 2000 Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial Ann Surg Oncol 7 87 97
3. N Cascinelli A Morabito M Santinami 1998 Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme Lancet 351 793 6
4. U Veronesi J Adamus DC Bandiera 1982 Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities Cancer 49 2420 30
5. DL Morton DR Wen JH Wong 1992 Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 392 9
6. N Cascinelli F Belli M Santinami 2000 Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience Ann Surg Oncol 7 469 74
7. N Cascinelli 1999 WHO declares lymphatic mapping to be standard of care for melanoma Oncology 13 288
8. CM Balch AC Buzaid SJ Soong 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 48
9. CM Balch SJ Soong JE Gershenwald 2001 Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 3622 34
10. ZI Nowecki P Rutkowski A Nasierowska-Guttmejer 2003 Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes-one institution's experience Melanoma Res 13 35 43
11. RJ Vuylsteke PA van Leeuwen MG Statius Muller 2003 Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results J Clin Oncol 21 1057 65
12. JE Gershenwald W Thompson PF Mansfield 1999 Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 976 83
13. JF Thompson HW Shaw 2007 Sentinel node mapping for melanoma: results of trials and current applications Surg Oncol Clin N Am 16 35 54
14. KM McMasters DS Reintgen MI Ross 2001 Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement J Clin Oncol 19 2851 5
15. DL Morton JF Thompson AJ Cochran 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 1307 17
16. P Rutkowski ZI Nowecki Z Zurawski 2006 In-transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection Eur J Cancer 42 159 64
17. AC van Akkooi JH de Wilt C Verhoef 2006 High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma Eur J Cancer 42 372 80
18. MG Statius Muller PA van Leeuwen ES de Lange-De Klerk 2001 The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma Cancer 91 2401 8
19. CP Karakousis 1998 Therapeutic node dissections in malignant melanoma Semin Surg Oncol 14 291 301
20. AMM Eggermont S Suciu R MacKie 2005 Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomized controlled trial Lancet 366 1189 96
21. AMM Eggermont M Gore 2007 Randomized adjuvant therapy trials in melanoma: surgical and systemic Semin Oncol 34 509 15
22. CM Balch S-J Soong R Desmond 2005 In reply J Clin Oncol 23 9428
23. D Berd MJ Mastrangelo T Sato 2005 Calculation of survival of patients with stage III melanoma J Clin Oncol 23 9427
24. A Petro J Schwartz T Johnson 2004 Current melanoma staging Clin Dermatol 22 223 7
25. U Leiter F Meier B Schittek 2004 The natural course of cutaneous melanoma J Surg Oncol 86 172 8
26. L Kretschmer KP Preusser WC Marsch 2000 Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanoma Melanoma Res 10 483 9
27. F Meier S Will U Ellwanger 2002 Metastatic pathways and time courses in the orderly progression of cutaneous melanoma Br J Dermatol 147 62 70
28. TA Aloia JE Gershenwald RH Andtbacka 2006 Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma J Clin Oncol 24 2858 65
29. JS Gold DP Jaques KJ Busam 2007 Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy Ann Surg Oncol 14 2133 40
30. L Kretschmer 2004 Patients with lymphatic metastasis of cutaneous melanoma benefit from lymphonodectomy and early excision of their nodal disease Eur J Cancer 40 212 8
31. S Retsasa MJ Mastrangelo 2007 Reflecting on the 2001 American Joint Committee on Cancer Staging System for Melanoma Semin Oncol 34 491 7
32. N Cascinelli E Bombardieri R Bufalino 2006 Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival J Clin Oncol 24 4464 71
33. AC van Akkooi MG Bouwhuis AN van Geel 2007 Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma Eur J Surg Oncol 33 102 8
34. T Meyer S Merkel J Göhl 2002 Lymph node dissection for clinically evident lymph node metastases of malignant melanoma Eur J Surg Oncol 28 424 30
35. GE Messaris MM Konstadoulakis N Ricaniadis 2000 Prognostic variables for patients with stage III malignant melanoma Eur J Surg 166 233 9
36. TMD Hughes RP A'Hern JM Thomas 2000 Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma Br J Surg 87 892 901
37. AC van Akkooi MG Bouwhuis JH de Wilt 2007 Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma Br J Surg 94 1293 9
38. B Badgwell Y Xing JE Gershenwald 2007 Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma Ann Surg Oncol 14 2867 75
39. CP Karakousis DL Driscoll 1996 Positive deep nodes in the groin and survival in malignant melanoma Am J Surg 171 421 2
40. A Doubrovsky JHW de Wilt RA Scolyer 2004 Sentinel node biopsy provides more accurate staging than elective lymph node dissection In patients with cutaneous melanoma Ann Surg Oncol 11 829 36
41. CM Balch N Cascinelli 2006 Editorials: sentinel-node in melanoma N Engl J Med 355 1370 2
42. DL Morton DS Hoon AJ Cochran 2003 Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases Ann Surg 238 538 50
43. R Essner A Conforti MC Kelley 1999 Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma Ann Surg Oncol 6 442 9
44. F Roka H Kittler P Cauzig 2005 Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis Br J Cancer 92 662 7
45. R Gutzmer M Al Ghazal H Geerlings 2005 Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients Br J Dermatol 153 1137 41
46. P Rutkowski ZI Nowecki A Nasierowska-Guttmejer 2003 Lymph node status and survival in cutaneous malignant melanoma-sentinel lymph node biopsy impact Eur J Surg Oncol 29 611 8
47. GW Carlson DR Murray RH Lyles 2003 The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 10 575 81
48. RP Scheri R Essner RR Turner 2007 Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma Ann Surg Oncol 14 2861 6
49. AC van Akkooi JH de Wilt C Verhoef 2006 Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 17 1578 85
50. van Akkooi AC, Nowecki ZI, Voit C, et al. Prognosis depends on micro-anatomic patterns of melanoma micrometastases within the sentinel node (SN). A multicenter study in 388 SN positive patients. Eur J Cancer - Supplements 2007; 5:397:abstract 7006
51. JE Gershenwald PF Mansfield JF Lee 2000 Role for lymphatic mapping an sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma Ann Surg Oncol 7 160 5
52. JM Thomas 2008 Prognostic false-positivity of the sentinel node in melanoma Nat Clin Pract Oncol 5 18 23